Updated Jul 16, 2026
Kelly Michael has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Based on SEC filings, Kelly Michael is listed in connection with ARS Pharmaceuticals, Inc. as of June 26, 2026. The available context does not specify whether this person is a director, officer, or beneficial owner. There is no widely published biographical information readily verifiable from standard sources about this exact name in relation to ARS Pharmaceuticals. Therefore, the biography is limited to confirming association with ARS Pharmaceuticals and the date of the most recent SEC filing; further verification from ARS's Form 4s, 8-Ks, or investor relations materials is required to determine the role, background, and career history.
| Role | Insider |
|---|---|
| Notability | 12/100 |
Based on SEC filings, Kelly Michael is listed in connection with ARS Pharmaceuticals, Inc. as of June 26, 2026. The available context does not specify whether this person is a director, officer, or beneficial owner. There is no widely published biographical information readily verifiable from standard sources about this exact name in relation to ARS Pharmaceuticals. Therefore, …
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Kelly Michael profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.